Fei Zhou

This inventor holds 11 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Astrazeneca Ab, Entasis Therapeutics, Inc.. Active years: 2007-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fei Zhou. Retrieved from https://idiyas.com/inventor/fei-zhou-4uudwiss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 3)

% Patents Active = 54.5

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 102(Granted Patents)

Location History:

Southborough, MA (US) (2013)
Waltham, MA (US) (2007 - 2015)
Jamaica Plain, MA (US) (2017)

Company Filing History:

Entasis Therapeutics, Inc.

patents

Years Active: 2007-2017

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9839641 - Compounds and methods for treating bacterial infections (2017-12-12),

2. 9540394 - Compounds and methods for treating bacterial infections (2017-01-10),

3. 9187495 - Compounds and methods for treating bacterial infections (2015-11-17),

4. 9040528 - Chemical compounds 542 (2015-05-26),

5. 8889671 - Compounds and methods for treating bacterial infections (2014-11-18),

6. 8658641 - Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections (2014-02-25),

7. 8399489 - Antibacterial piperdine derivatives (2013-03-19),

8. 8071605 - Piperidine compounds for use in the treatment of bacterial infections (2011-12-06),

9. 7498350 - Oxazolidinones as antibacterial agents (2009-03-03),

10. 7473699 - 3-cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and their use as antibacterial agents (2009-01-06),

11. 7199143 - Chemical compounds (2007-04-03),

Title: Fei Zhou: Innovator in Bacterial Infection Treatment

Introduction

Fei Zhou is a prominent inventor based in Waltham, MA (US), known for his significant contributions to the field of pharmaceutical sciences. With a total of 11 patents to his name, he has made remarkable strides in developing compounds and methods for treating bacterial infections.

Latest Patents

Among his latest patents, Fei Zhou has disclosed compounds of formula (I), which include pharmaceutically acceptable salts and their uses for treating bacterial infections. This innovative approach aims to provide effective solutions in combating bacterial pathogens, showcasing his commitment to advancing medical treatments.

Career Highlights

Fei Zhou has worked with notable companies such as AstraZeneca and Entasis Therapeutics, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the pharmaceutical industry, further enhancing his expertise and impact in the field.

Collaborations

Fei Zhou has collaborated with esteemed colleagues, including Gregory Steven Basarab and Sheila Irene Hauck. These partnerships have contributed to the development of groundbreaking treatments and have fostered a collaborative environment for innovation.

Conclusion

In summary, Fei Zhou is a distinguished inventor whose work in developing treatments for bacterial infections has made a significant impact in the pharmaceutical industry. His dedication to innovation and collaboration continues to drive advancements in medical science.

Profile summary based on public USPTO records.